The advertisement promotes NUBEQA (darolutamide) as a treatment option, highlighting important safety information regarding ischemic heart disease associated with its use.
Creative Information
| CID: | c36fc028-e7bb-4acb-a938-7f9ffd342152 |
| CRID: | 82_1075-923957 |
| Domain: | nubeqahcp.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $35.84 |
| Timestamp: | 11/18/2025, 9:55:15 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/19/2025, 1:28:03 AM | 6.48s | |
| adomain_analysis | success | 11/19/2025, 2:56:38 AM | 3.80s | |
| adomain_capture | success | 11/19/2025, 2:56:34 AM | 0.09s | |
| ad_render | success | 11/19/2025, 1:27:56 AM | 24.79s | |
| brand_mapping | success | 11/18/2025, 9:55:15 PM | 0.11s | |
Analysis Results
Ad Format: banner
Brands: NUBEQA
Sensitive:Misleading Health ClaimsUnverified Medical TreatmentsPharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1104.57 KB | ||||||||||||||||||||||
| Render Time: | 9.24 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1104.61 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


